Q, Y. C., JANE, B., MS, B. J., & C, B. P. (2018). GENE SIGNATURE OF RESIDUAL RISK FOLLOWING ENDOCRINE TREATMENT IN EARLY BREAST CANCER.
Chicago Style (17th ed.) CitationQ, YAO CINDY, BAYANI JANE, BARTLETT JOHN MS, and BOUTROS PAUL C. GENE SIGNATURE OF RESIDUAL RISK FOLLOWING ENDOCRINE TREATMENT IN EARLY BREAST CANCER. 2018.
MLA (9th ed.) CitationQ, YAO CINDY, et al. GENE SIGNATURE OF RESIDUAL RISK FOLLOWING ENDOCRINE TREATMENT IN EARLY BREAST CANCER. 2018.
Warning: These citations may not always be 100% accurate.